ALISON HOFFMAN: Open Payments
NPI 1598025702 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 29 payments from 19 companies in 2025. Trend: 2023 $828 · 2024 $799 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $272 |
| Stemline Therapeutics Inc. | 2 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Nalu Medical, Inc. | 1 | $55 |
| GENZYME CORPORATION | 1 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $28 |
Products named: RYBREVANT, Orserdu, KISQALI, Nalu Neurostimulation System, SARCLISA, DARZALEX, ULTOMIRIS, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
